Pharma & Healthcare

Global Immune Checkpoint Proteins Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Immune Checkpoint Proteins market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
MedChemExpress
Bio-Techne
ProteoGenix
Creative BioMart
GenScript
Bio X Cell
KACTUS
DIMA Biotechnology
Creative Biolabs
Leinco Technologies
ACROBiosystems
Elabscience
ProbeChem
Sino Biological
Segment by Type
Immune Checkpoint Inhibitory Proteins
Immune Checkpoint Stimulatory Proteins
Segment by Application
Cancer Immunotherapy
Autoimmune Disease Treatment
Others
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Immune Checkpoint Proteins study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Immune Checkpoint Proteins: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Immune Checkpoint Proteins Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Immune Checkpoint Inhibitory Proteins
1.2.3 Immune Checkpoint Stimulatory Proteins
1.3 Market Segmentation by Application
1.3.1 Global Immune Checkpoint Proteins Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cancer Immunotherapy
1.3.3 Autoimmune Disease Treatment
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immune Checkpoint Proteins Revenue Estimates and Forecasts 2020-2031
2.2 Global Immune Checkpoint Proteins Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Immune Checkpoint Proteins Sales Estimates and Forecasts 2020-2031
2.4 Global Immune Checkpoint Proteins Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Immune Checkpoint Proteins Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Immune Checkpoint Proteins Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Immune Checkpoint Inhibitory Proteins Market Size by Manufacturers
3.5.2 Immune Checkpoint Stimulatory Proteins Market Size by Manufacturers
3.6 Global Immune Checkpoint Proteins Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Immune Checkpoint Proteins Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Immune Checkpoint Proteins Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Immune Checkpoint Proteins Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Immune Checkpoint Proteins Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Immune Checkpoint Proteins Sales and Revenue by Type (2020-2031)
6.4 North America Immune Checkpoint Proteins Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Immune Checkpoint Proteins Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Immune Checkpoint Proteins Sales and Revenue by Type (2020-2031)
7.4 Europe Immune Checkpoint Proteins Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Immune Checkpoint Proteins Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Immune Checkpoint Proteins Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Immune Checkpoint Proteins Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Immune Checkpoint Proteins Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Immune Checkpoint Proteins Sales and Revenue by Type (2020-2031)
9.4 Central and South America Immune Checkpoint Proteins Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Immune Checkpoint Proteins Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Immune Checkpoint Proteins Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Immune Checkpoint Proteins Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Immune Checkpoint Proteins Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MedChemExpress
11.1.1 MedChemExpress Corporation Information
11.1.2 MedChemExpress Business Overview
11.1.3 MedChemExpress Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.1.4 MedChemExpress Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MedChemExpress Immune Checkpoint Proteins Sales by Product in 2024
11.1.6 MedChemExpress Immune Checkpoint Proteins Sales by Application in 2024
11.1.7 MedChemExpress Immune Checkpoint Proteins Sales by Geographic Area in 2024
11.1.8 MedChemExpress Immune Checkpoint Proteins SWOT Analysis
11.1.9 MedChemExpress Recent Developments
11.2 Bio-Techne
11.2.1 Bio-Techne Corporation Information
11.2.2 Bio-Techne Business Overview
11.2.3 Bio-Techne Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.2.4 Bio-Techne Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bio-Techne Immune Checkpoint Proteins Sales by Product in 2024
11.2.6 Bio-Techne Immune Checkpoint Proteins Sales by Application in 2024
11.2.7 Bio-Techne Immune Checkpoint Proteins Sales by Geographic Area in 2024
11.2.8 Bio-Techne Immune Checkpoint Proteins SWOT Analysis
11.2.9 Bio-Techne Recent Developments
11.3 ProteoGenix
11.3.1 ProteoGenix Corporation Information
11.3.2 ProteoGenix Business Overview
11.3.3 ProteoGenix Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.3.4 ProteoGenix Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 ProteoGenix Immune Checkpoint Proteins Sales by Product in 2024
11.3.6 ProteoGenix Immune Checkpoint Proteins Sales by Application in 2024
11.3.7 ProteoGenix Immune Checkpoint Proteins Sales by Geographic Area in 2024
11.3.8 ProteoGenix Immune Checkpoint Proteins SWOT Analysis
11.3.9 ProteoGenix Recent Developments
11.4 Creative BioMart
11.4.1 Creative BioMart Corporation Information
11.4.2 Creative BioMart Business Overview
11.4.3 Creative BioMart Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.4.4 Creative BioMart Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Creative BioMart Immune Checkpoint Proteins Sales by Product in 2024
11.4.6 Creative BioMart Immune Checkpoint Proteins Sales by Application in 2024
11.4.7 Creative BioMart Immune Checkpoint Proteins Sales by Geographic Area in 2024
11.4.8 Creative BioMart Immune Checkpoint Proteins SWOT Analysis
11.4.9 Creative BioMart Recent Developments
11.5 GenScript
11.5.1 GenScript Corporation Information
11.5.2 GenScript Business Overview
11.5.3 GenScript Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.5.4 GenScript Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 GenScript Immune Checkpoint Proteins Sales by Product in 2024
11.5.6 GenScript Immune Checkpoint Proteins Sales by Application in 2024
11.5.7 GenScript Immune Checkpoint Proteins Sales by Geographic Area in 2024
11.5.8 GenScript Immune Checkpoint Proteins SWOT Analysis
11.5.9 GenScript Recent Developments
11.6 Bio X Cell
11.6.1 Bio X Cell Corporation Information
11.6.2 Bio X Cell Business Overview
11.6.3 Bio X Cell Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.6.4 Bio X Cell Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Bio X Cell Recent Developments
11.7 KACTUS
11.7.1 KACTUS Corporation Information
11.7.2 KACTUS Business Overview
11.7.3 KACTUS Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.7.4 KACTUS Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 KACTUS Recent Developments
11.8 DIMA Biotechnology
11.8.1 DIMA Biotechnology Corporation Information
11.8.2 DIMA Biotechnology Business Overview
11.8.3 DIMA Biotechnology Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.8.4 DIMA Biotechnology Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 DIMA Biotechnology Recent Developments
11.9 Creative Biolabs
11.9.1 Creative Biolabs Corporation Information
11.9.2 Creative Biolabs Business Overview
11.9.3 Creative Biolabs Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.9.4 Creative Biolabs Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Creative Biolabs Recent Developments
11.10 Leinco Technologies
11.10.1 Leinco Technologies Corporation Information
11.10.2 Leinco Technologies Business Overview
11.10.3 Leinco Technologies Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.10.4 Leinco Technologies Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Leinco Technologies Recent Developments
11.11 ACROBiosystems
11.11.1 ACROBiosystems Corporation Information
11.11.2 ACROBiosystems Business Overview
11.11.3 ACROBiosystems Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.11.4 ACROBiosystems Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 ACROBiosystems Recent Developments
11.12 Elabscience
11.12.1 Elabscience Corporation Information
11.12.2 Elabscience Business Overview
11.12.3 Elabscience Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.12.4 Elabscience Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Elabscience Recent Developments
11.13 ProbeChem
11.13.1 ProbeChem Corporation Information
11.13.2 ProbeChem Business Overview
11.13.3 ProbeChem Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.13.4 ProbeChem Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 ProbeChem Recent Developments
11.14 Sino Biological
11.14.1 Sino Biological Corporation Information
11.14.2 Sino Biological Business Overview
11.14.3 Sino Biological Immune Checkpoint Proteins Product Models, Descriptions and Specifications
11.14.4 Sino Biological Immune Checkpoint Proteins Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Sino Biological Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Immune Checkpoint Proteins Industry Chain
12.2 Immune Checkpoint Proteins Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Immune Checkpoint Proteins Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Immune Checkpoint Proteins Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Immune Checkpoint Proteins Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Immune Checkpoint Proteins Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Immune Checkpoint Proteins Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Immune Checkpoint Proteins Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Immune Checkpoint Proteins Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Immune Checkpoint Proteins Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Immune Checkpoint Proteins Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Immune Checkpoint Proteins Sales by Region (2020-2025) & (kg)
Table 8. Global Immune Checkpoint Proteins Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Immune Checkpoint Proteins Sales by Manufacturers (2020-2025) & (kg)
Table 11. Global Immune Checkpoint Proteins Sales Share by Manufacturers (2020-2025)
Table 12. Global Immune Checkpoint Proteins Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Immune Checkpoint Proteins Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Immune Checkpoint Proteins by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Checkpoint Proteins as of 2024)
Table 16. Global Immune Checkpoint Proteins Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Immune Checkpoint Proteins Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/kg)
Table 18. Key Manufacturers Immune Checkpoint Proteins Manufacturing Base and Headquarters
Table 19. Global Immune Checkpoint Proteins Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Immune Checkpoint Proteins Sales by Type (2020-2025) & (kg)
Table 23. Global Immune Checkpoint Proteins Sales by Type (2026-2031) & (kg)
Table 24. Global Immune Checkpoint Proteins Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Immune Checkpoint Proteins Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Immune Checkpoint Proteins ASP by Type (2020-2031) & (US$/kg)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Immune Checkpoint Proteins Sales by Application (2020-2025) & (kg)
Table 29. Global Immune Checkpoint Proteins Sales by Application (2026-2031) & (kg)
Table 30. Immune Checkpoint Proteins High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Immune Checkpoint Proteins Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Immune Checkpoint Proteins Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Immune Checkpoint Proteins ASP by Application (2020-2031) & (US$/kg)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Immune Checkpoint Proteins Growth Accelerators and Market Barriers
Table 37. North America Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Immune Checkpoint Proteins Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Immune Checkpoint Proteins Growth Accelerators and Market Barriers
Table 40. Europe Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Immune Checkpoint Proteins Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Immune Checkpoint Proteins Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Immune Checkpoint Proteins Growth Accelerators and Market Barriers
Table 45. Southeast Asia Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Immune Checkpoint Proteins Investment Opportunities and Key Challenges
Table 47. Central and South America Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Immune Checkpoint Proteins Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Immune Checkpoint Proteins Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. MedChemExpress Corporation Information
Table 51. MedChemExpress Description and Major Businesses
Table 52. MedChemExpress Product Models, Descriptions and Specifications
Table 53. MedChemExpress Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 54. MedChemExpress Sales Value Proportion by Product in 2024
Table 55. MedChemExpress Sales Value Proportion by Application in 2024
Table 56. MedChemExpress Sales Value Proportion by Geographic Area in 2024
Table 57. MedChemExpress Immune Checkpoint Proteins SWOT Analysis
Table 58. MedChemExpress Recent Developments
Table 59. Bio-Techne Corporation Information
Table 60. Bio-Techne Description and Major Businesses
Table 61. Bio-Techne Product Models, Descriptions and Specifications
Table 62. Bio-Techne Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 63. Bio-Techne Sales Value Proportion by Product in 2024
Table 64. Bio-Techne Sales Value Proportion by Application in 2024
Table 65. Bio-Techne Sales Value Proportion by Geographic Area in 2024
Table 66. Bio-Techne Immune Checkpoint Proteins SWOT Analysis
Table 67. Bio-Techne Recent Developments
Table 68. ProteoGenix Corporation Information
Table 69. ProteoGenix Description and Major Businesses
Table 70. ProteoGenix Product Models, Descriptions and Specifications
Table 71. ProteoGenix Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 72. ProteoGenix Sales Value Proportion by Product in 2024
Table 73. ProteoGenix Sales Value Proportion by Application in 2024
Table 74. ProteoGenix Sales Value Proportion by Geographic Area in 2024
Table 75. ProteoGenix Immune Checkpoint Proteins SWOT Analysis
Table 76. ProteoGenix Recent Developments
Table 77. Creative BioMart Corporation Information
Table 78. Creative BioMart Description and Major Businesses
Table 79. Creative BioMart Product Models, Descriptions and Specifications
Table 80. Creative BioMart Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 81. Creative BioMart Sales Value Proportion by Product in 2024
Table 82. Creative BioMart Sales Value Proportion by Application in 2024
Table 83. Creative BioMart Sales Value Proportion by Geographic Area in 2024
Table 84. Creative BioMart Immune Checkpoint Proteins SWOT Analysis
Table 85. Creative BioMart Recent Developments
Table 86. GenScript Corporation Information
Table 87. GenScript Description and Major Businesses
Table 88. GenScript Product Models, Descriptions and Specifications
Table 89. GenScript Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. GenScript Sales Value Proportion by Product in 2024
Table 91. GenScript Sales Value Proportion by Application in 2024
Table 92. GenScript Sales Value Proportion by Geographic Area in 2024
Table 93. GenScript Immune Checkpoint Proteins SWOT Analysis
Table 94. GenScript Recent Developments
Table 95. Bio X Cell Corporation Information
Table 96. Bio X Cell Description and Major Businesses
Table 97. Bio X Cell Product Models, Descriptions and Specifications
Table 98. Bio X Cell Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 99. Bio X Cell Recent Developments
Table 100. KACTUS Corporation Information
Table 101. KACTUS Description and Major Businesses
Table 102. KACTUS Product Models, Descriptions and Specifications
Table 103. KACTUS Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 104. KACTUS Recent Developments
Table 105. DIMA Biotechnology Corporation Information
Table 106. DIMA Biotechnology Description and Major Businesses
Table 107. DIMA Biotechnology Product Models, Descriptions and Specifications
Table 108. DIMA Biotechnology Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 109. DIMA Biotechnology Recent Developments
Table 110. Creative Biolabs Corporation Information
Table 111. Creative Biolabs Description and Major Businesses
Table 112. Creative Biolabs Product Models, Descriptions and Specifications
Table 113. Creative Biolabs Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 114. Creative Biolabs Recent Developments
Table 115. Leinco Technologies Corporation Information
Table 116. Leinco Technologies Description and Major Businesses
Table 117. Leinco Technologies Product Models, Descriptions and Specifications
Table 118. Leinco Technologies Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 119. Leinco Technologies Recent Developments
Table 120. ACROBiosystems Corporation Information
Table 121. ACROBiosystems Description and Major Businesses
Table 122. ACROBiosystems Product Models, Descriptions and Specifications
Table 123. ACROBiosystems Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 124. ACROBiosystems Recent Developments
Table 125. Elabscience Corporation Information
Table 126. Elabscience Description and Major Businesses
Table 127. Elabscience Product Models, Descriptions and Specifications
Table 128. Elabscience Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 129. Elabscience Recent Developments
Table 130. ProbeChem Corporation Information
Table 131. ProbeChem Description and Major Businesses
Table 132. ProbeChem Product Models, Descriptions and Specifications
Table 133. ProbeChem Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 134. ProbeChem Recent Developments
Table 135. Sino Biological Corporation Information
Table 136. Sino Biological Description and Major Businesses
Table 137. Sino Biological Product Models, Descriptions and Specifications
Table 138. Sino Biological Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 139. Sino Biological Recent Developments
Table 140. Key Raw Materials Distribution
Table 141. Raw Materials Key Suppliers
Table 142. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 143. Milestones in Production Technology Evolution
Table 144. Distributors List
Table 145. Market Trends and Market Evolution
Table 146. Market Drivers and Opportunities
Table 147. Market Challenges, Risks, and Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources


List of Figures
Figure 1. Immune Checkpoint Proteins Product Picture
Figure 2. Global Immune Checkpoint Proteins Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Immune Checkpoint Inhibitory Proteins Product Picture
Figure 4. Immune Checkpoint Stimulatory Proteins Product Picture
Figure 5. Global Immune Checkpoint Proteins Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Cancer Immunotherapy
Figure 7. Autoimmune Disease Treatment
Figure 8. Others
Figure 9. Immune Checkpoint Proteins Report Years Considered
Figure 10. Global Immune Checkpoint Proteins Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 12. Global Immune Checkpoint Proteins Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Immune Checkpoint Proteins Revenue Market Share by Region (2020-2031)
Figure 14. Global Immune Checkpoint Proteins Sales (2020-2031) & (kg)
Figure 15. Global Immune Checkpoint Proteins Sales (CAGR) by Region (2020-2031) (kg)
Figure 16. Global Immune Checkpoint Proteins Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Immune Checkpoint Proteins Sales Volume Market Share in 2024
Figure 18. Global Immune Checkpoint Proteins Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Immune Checkpoint Inhibitory Proteins Revenue Market Share by Manufacturer in 2024
Figure 21. Immune Checkpoint Stimulatory Proteins Revenue Market Share by Manufacturer in 2024
Figure 22. Global Immune Checkpoint Proteins Sales Market Share by Type (2020-2031)
Figure 23. Global Immune Checkpoint Proteins Revenue Market Share by Type (2020-2031)
Figure 24. Global Immune Checkpoint Proteins Sales Market Share by Application (2020-2031)
Figure 25. Global Immune Checkpoint Proteins Revenue Market Share by Application (2020-2031)
Figure 26. North America Immune Checkpoint Proteins Sales YoY (2020-2031) & (kg)
Figure 27. North America Immune Checkpoint Proteins Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Immune Checkpoint Proteins Sales Revenue (US$ Million) in 2024
Figure 29. North America Immune Checkpoint Proteins Sales Volume (kg) by Type (2020- 2031)
Figure 30. North America Immune Checkpoint Proteins Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Immune Checkpoint Proteins Sales Volume (kg) by Application (2020-2031)
Figure 32. North America Immune Checkpoint Proteins Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Immune Checkpoint Proteins Sales YoY (2020-2031) & (kg)
Figure 37. Europe Immune Checkpoint Proteins Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Immune Checkpoint Proteins Sales Revenue (US$ Million) in 2024
Figure 39. Europe Immune Checkpoint Proteins Sales Volume (kg) by Type (2020-2031)
Figure 40. Europe Immune Checkpoint Proteins Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Immune Checkpoint Proteins Sales Volume (kg) by Application (2020-2031)
Figure 42. Europe Immune Checkpoint Proteins Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 44. France Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Immune Checkpoint Proteins Sales YoY (2020-2031) & (kg)
Figure 49. Asia-Pacific Immune Checkpoint Proteins Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Immune Checkpoint Proteins Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Immune Checkpoint Proteins Sales Volume (kg) by Type (2020- 2031)
Figure 52. Asia-Pacific Immune Checkpoint Proteins Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Immune Checkpoint Proteins Sales Volume (kg) by Application (2020-2031)
Figure 54. Asia-Pacific Immune Checkpoint Proteins Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 59. India Immune Checkpoint Proteins Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Immune Checkpoint Proteins Sales YoY (2020-2031) & (kg)
Figure 61. Central and South America Immune Checkpoint Proteins Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Immune Checkpoint Proteins Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Immune Checkpoint Proteins Sales Volume (kg) by Type (2021-2031)
Figure 64. Central and South America Immune Checkpoint Proteins Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Immune Checkpoint Proteins Sales Volume (kg) by Application (2020-2031)
Figure 66. Central and South America Immune Checkpoint Proteins Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Immune Checkpoint Proteins Sales YoY (2020-2031) & (kg)
Figure 70. Middle East and Africa Immune Checkpoint Proteins Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Immune Checkpoint Proteins Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Immune Checkpoint Proteins Sales Volume (kg) by Type (2021-2031)
Figure 73. South America Immune Checkpoint Proteins Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Immune Checkpoint Proteins Sales Volume (kg) by Application (2020-2031)
Figure 75. Middle East and Africa Immune Checkpoint Proteins Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Immune Checkpoint Proteins Revenue (2020-2025) & (US$ Million)
Figure 80. Immune Checkpoint Proteins Industry Chain Mapping
Figure 81. Regional Immune Checkpoint Proteins Manufacturing Base Distribution (%)
Figure 82. Global Immune Checkpoint Proteins Production Market Share by Region (2020-2031)
Figure 83. Immune Checkpoint Proteins Production Process
Figure 84. Regional Immune Checkpoint Proteins Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies